SOURCE: Targeted Genetics

June 11, 2007 07:30 ET

Targeted Genetics to Present at the Sixth Annual Needham & Company Biotechnology and Medical Technology Conference

SEATTLE, WA--(Marketwire - June 11, 2007) - Targeted Genetics Corporation (NASDAQ: TGEN) announced today that H. Stewart Parker, president and chief executive officer, will present a company overview at sixth annual Needham & Company Biotechnology and Medical Technology Conference on Wednesday, June 13, at 8:30 a.m. at the New York Palace Hotel.

The presentation will be webcast live and available for replay from the Targeted Genetics' website, Links to connect can be found on the Company's homepage under the "Events" section.

About Targeted Genetics

Targeted Genetics Corporation is a biotechnology company committed to the development of innovative targeted molecular therapies for the prevention and treatment of acquired and inherited diseases with significant unmet medical need. Targeted Genetics' proprietary Adeno-Associated Virus (AAV) technology platform allows it to deliver genes that encode proteins to increase gene function or RNAi to decrease or silence gene function. Targeted Genetics' product development efforts target inflammatory arthritis, AIDS prophylaxis, congestive heart failure and Huntington's disease. To learn more about Targeted Genetics, visit Targeted Genetics' website at

Contact Information

  • Investor and Media Contact:
    Stacie D. Byars
    Director, Communications
    Targeted Genetics Corporation
    (206) 521-7392